Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
Azur Medical from Wetteren, company number BE0674481778, closed financial year 2025 with a result of € -3,009 after tax. For that financial year Azur Medical recorded a gross margin of € -1,467 and equity of € 36,285. Compared with financial year 2024, the result moved from € -4,071 to € -3,009. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 36,285
▼ 8% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -3,009
▲ 26 % less loss than in 2024
Profit after tax over the fiscal year.
€ 13,254
▼ 31% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 16,285.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 531
▼ 19% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -3,405 | € -7,198 | € -2,536 | € -1,467 | ▲ € 1,069 |
| Profit after taxes | € -1,000 | € -8,275 | € -4,071 | € -3,009 | ▲ € 1,062 |
| Equity | € 51,640 | € 43,366 | € 39,294 | € 36,285 | ▼ 8% |
| Total debts | € 1,048 | € 15,518 | € 1,179 | € 535 | ▼ 55% |
| Cash | € 51,714 | € 23,142 | € 19,221 | € 13,254 | ▼ 31% |
| Retained profit | € 31,640 | € 23,366 | € 19,294 | € 16,285 | ▼ 16% |
| Balance sheet total | € 52,688 | € 58,884 | € 40,474 | € 36,820 | ▼ 9% |
Key figures of Azur Medical, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Azur Medical?
What happened at Azur Medical in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 3,009. filed late Source: NBB ↗
- New establishment in Wetteren. KBO
- Start of the company according to the CBE. KBO
In short
From € 1,000 loss in 2022 to € 3,009 loss in 2025.
Management
Behind Azur Medical are MD CONSULT BV BV and PHARCOSSOL BV BV. MD CONSULT BV BV is also behind Ceres Pharmaceuticals, VESALE PHARMACEUTICA, 2PHARMA HOLDING, MD Pharma and AUGMENTED ANATOMY. PHARCOSSOL BV BV is also behind CIMA, Ingrizo and ADISO.
Directors
According to the 2025 annual accounts
Director · represented by Mario Debel
Also active at: Ceres Pharmaceuticals, VESALE PHARMACEUTICA, 2PHARMA HOLDING, MD Pharma, AUGMENTED ANATOMY, GLOBIFER INTL, CREDOPHAR, 2PHARMA
Establishments
Establishment units
Physical locations of this company
Lege Weg 23
9230 Wetteren
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0674.481.778
- VAT number
- BE 0674.481.778
- Registered office
- Lege Weg 23, 9230 Wetteren
- Names & denominations
- Azur Medical
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 April 2017
- Peppol
- Active · Active since 7 Apr 2026
- Activities · NACE
Vervaardiging van parfums en toiletartikelen
Detailhandel in cosmetica en toiletartikelen
Groothandel in parfumerieën en cosmetica